National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism

Obstetrics and Gynecology

Volumn 128, Issue 4, 2016, Pages 688-698

  D'Alton, Mary E ^a   Friedman, Alexander M ^a   Smiley, Richard M ^a   Montgomery, Douglas M ^a   Paidas, Michael J ^a   D'Oria, Robyn ^a   Frost, Jennifer L ^a   Hameed, Afshan B ^a   Karsnitz, Deborah ^a   Levy, Barbara S ^a   Clark, Steven L ^a  

^a New York Presbyterian Columbia University Medical Center

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANESTHESIA; ANTICOAGULANT THERAPY; ARTICLE; CESAREAN SECTION; CLINICAL PRACTICE; CONSENSUS; EVIDENCE BASED PRACTICE; FEMALE; GYNECOLOGIST; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; MATERNAL CARE; MATERNAL DEATH; MATERNAL MORBIDITY; MATERNAL MORTALITY; OBSTETRIC PATIENT; OBSTETRICIAN; OUTPATIENT CARE; PATIENT SAFETY; PREGNANCY DISORDER; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); THROMBOSIS PREVENTION; UNITED STATES; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM; BIRTH; CHEMICALLY INDUCED; PERINATAL PERIOD; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; THROMBOCYTOPENIA; TIME FACTOR;

ANTICOAGULANTS; CESAREAN SECTION; CONSENSUS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PARTURITION; PERIPARTUM PERIOD; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK ASSESSMENT; THROMBOCYTOPENIA; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84986204839     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001579     Document Type: Article

References (34)

1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death a systematic review. Lancet 2006;367:1066-74
2. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(suppl 1): 1-203
3. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015;125:5-12
4. Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008;199:36.e1-5
5. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010;251: 344-50
6. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010;8: 2450-7
7. Inherited thrombophilias in pregnancy. Practice Bulletin No. 138. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;122:706-17
8. Thromboembolism in pregnancy. Practice Bulletin No. 123. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;118:718-29
9. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e691S-736S
10. Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. The Cochrane Database of Systematic Reviews 2014, Issue 2 Art. No.: CD001689. DOI: 10.1002/14651858.CD001689.pub3
11. Clark SL, Christmas JT, Frye DR, Meyers JA, Perlin JB. Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage. Am J Obstet Gynecol 2014;211:32. e1-9
12. D'Alton ME, Main EK, Menard MK, Levy BS. The National Partnership for Maternal Safety. Obstet Gynecol 2014;123: 973-7
13. Main EK, Goffman D, Scavone BM, Low LK, Bingham D, Fontaine PL, et al. National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage. Obstet Gynecol 2015;126:155-62
14. Friedman AM, Ananth CV, Lu YS, D'Alton ME, Wright JD. Underuse of postcesarean thromboembolism prophylaxis. Obstet Gynecol 2013;122:1197-204
15. Ghaji N, Boulet SL, Tepper N, Hooper WC. Trends in venous thromboembolism among pregnancy-related hospitalizations, United States, 1994-2009. Am J Obstet Gynecol 2013;209: 433.e1-8
16. Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol 2012;120:1029-36
17. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-A register-based case-control study. Am J Obstet Gynecol 2008;198:233.e1-7
18. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311-5
19. Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM, Nelson-Piercy C, et al. Risk factors for first venous thromboembolism around pregnancy a population-based cohort study from the United Kingdom. Blood 2013;121:3953-61
20. Friedman AM, Ananth CV, Prendergast E, Chauhan SP, D'Alton ME, Wright JD. Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations. Am J Obstet Gynecol 2015;212:221.e1-12
21. The Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green-top Guideline No. 37a. April 2015. Available at: https://www.rcog.org.uk/globalassets/documents/ guidelines/gtg-37a.pdf. Retrieved June 28, 2016
22. The Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-Top Guideline No. 37a. November 2009. Available at: http://www.1000livesplus.wales.nhs.uk/sitesplus/ documents/1011/1%20RCOG%20GUIDANCE%20RED% 20RISK%20OF%20VTE.pdf. Retrieved June 28, 2016
23. The Royal College of Obstetricians and Gynecologists. Thromboprophylaxis during pregnancy, labour and after vaginal delivery. Guideline No. January 2004. Available at: http://faculty. ksu.edu.sa/FG/VTE%20and%20Pregnancy/Thromboprophylaxis %20in%20preganacy%202004.pdf. Retrieved July 18, 2016
24. Knight M, Tuffnell D, Kenyon S, Shakespeare J, Gray R, Kurinczuk JJ, editors. Saving lives, improving mothers' care-surveillance of maternal deaths in the UK 2011-13 and lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2009-13. Oxford (United Kingdom): National Perinatal Epidemiology Unit, University of Oxford; 2015
25. The Joint Commission. Approved: more options for hospital core measures. Available at: http://www.jointcommission.org/ assets/1/18/S4-JCP-04-09.pdf. Retrieved May 15, 2016
26. Blanchette H. The rising cesarean delivery rate in America: what are the consequences? Obstet Gynecol 2011;118:687-90
27. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e227-77S
28. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e195-226S
29. Brady MA, Carroll AW, Cheang KI, Straight C, Chelmow D. Sequential compression device compliance in postoperative obstetrics and gynecology patients. Obstet Gynecol 2015;125:19-25
30. Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:695-703
31. American Society of Regional Anesthesia and Pain Medicine. ASRA Coags (Version 1.5) [Mobile application software]. Available at https://itunes.apple.com/us/app/asra-coags/id858796572?mt58. Retrieved June 28, 2016
32. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med 2010;35:64-101
33. Palmerola KL, Brock CO, D'Alton ME, Friedman AM. Compliance with mechanical venous thromboproembolism prophylaxis after cesarean delivery. J Matern Fetal Neonatal Med 2015:1-4
34. Prevention of deep vein thrombosis and pulmonary embolism. ACOG Practice Bulletin No. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110: 429-40